Close

Add impact to your LinkedIn

Keep up with the latest updates, insights, and opportunities driving meaningful change in 
the healthcare industries

Follow us

Link
anchor

Who
We are

ARCHIMED is focused on accelerating the development of healthcare industries and solutions to the benefit of people and patients around the world.

+10,000

people employed

by ARCHIMED companies.

ARCHIMED was founded by healthcare professionals who shared the same passion of making a true impact in the healthcare industries. Watch the video to discover the story of ARCHIMED.

Play
0.00
Volume

WHAT
WE DO

We fund, support and scale companies whose activities contribute to improve health outcomes at all levels.

Citieffe

Natus Medical Incorporated

Primo Group

Clean Biologics (ex Clean Cells)

ActiGraph

Natural Origins

20%

average annual topline growth
of ARCHIMED companies.

HOW
WE DO IT

We join forces with scientists, healthcare professionals, entrepreneurs and investors through our 3 main activities:

FUND

We fund healthcare industries globally.

Our latest project:

SeqCenter

SUPPORT

We support healthcare entrepreneurs in their companies’ development.

Our latest project:

Ad-Tech

RETURN

We deliver superior returns to our Investors and to society.

Our latest project:

Clubhouse

FUND

We fund healthcare industries globally.

Our latest project:

SeqCenter

SUPPORT

We support healthcare entrepreneurs in their companies’ development.

Our latest project:

Ad-Tech

RETURN

We deliver superior returns to our Investors and to society.

Our latest project:

Clubhouse

LATEST
NEWS

November 26, 2024

ARCHIMED earns 5x its investment, selling a majority of Ad-Tech to Tokyo-listed Nihon Kohden

As part of the transaction, Nihon Kohden, one of the largest developers and distributors of medical electronic equipment in the world, is entering a joint-venture with ARCHIMED to pursue Ad-Tech’s growth in North America, Europe, and Asia.

November 8, 2024

ARCHIMED acquires SeqCenter, a fast-growing player in cutting-edge DNA and RNA gene sequencing

SeqCenter is a category leader in Next-Generation Sequencing, which can sequence hundreds of thousands of genes in record-time and at low cost.

October 15, 2024

ARCHIMED acquires FIM Medical, a leader in the vision, audio & respiratory medical devices market

Global private equity healthcare specialist ARCHIMED announces the acquisition of FIM Medical, the leader in the occupational health medical device market in France, with a strong international footprint.